Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers

BMC Gastroenterology

Volumn 9, Issue , 2009, Pages

  Krogius Kurikka, Lotta ^a   Lyra, Anna ^a   Malinen, Erja ^a   Aarnikunnas, Johannes ^a   Tuimala, Jarno ^b,g   Paulin, Lars ^c   Mäkivuokko, Harri ^d,g   Kajander, Kajsa ^e,f   Palva, Airi ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b IT Center for Science   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d Danisco Finland Oy   (Finland)

^e VALIO LTD   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

^g Finnish Red Cross   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CYTOSINE; GUANINE; RIBOSOME DNA; RNA 16S; BACTERIAL RNA;

ACTINOBACTERIA; ADULT; ARTICLE; BACTEROIDETES; CLINICAL ARTICLE; CONTROLLED STUDY; CORIOBACTERIALES; DIARRHEA; DNA CONTENT; DNA SEQUENCE; FECES MICROFLORA; FEMALE; FIRMICUTES; GAMMAPROTEOBACTERIA; GENE LIBRARY; HUMAN; INTESTINE FLORA; IRRITABLE COLON; LACHNOSPIRACEAE; MALE; MICROBIAL COMMUNITY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHYLOGENY; PHYLUM; PROTEOBACTERIA; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; UNINDEXED SEQUENCE; CASE CONTROL STUDY; CHEMISTRY; FECES; GASTROINTESTINAL TRACT; GENETICS; GRAM POSITIVE BACTERIUM; MICROBIOLOGY; MIDDLE AGED;

ACTINOBACTERIA; ADULT; BACTEROIDETES; CASE-CONTROL STUDIES; DIARRHEA; DNA, BACTERIAL; FECES; FEMALE; GASTROINTESTINAL TRACT; GRAM-POSITIVE BACTERIA; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PHYLOGENY; PROTEOBACTERIA; RNA, BACTERIAL;

EID: 74549185684     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-9-95     Document Type: Article

References (56)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006, 130(5):1480-1491. 10.1053/j.gastro.2005.11.061, 16678561.
2. Talley NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil 2008, 20(Suppl 1):121-129. 10.1111/j.1365-2982.2008.01097.x, 18402649.
3. Öhman L, Simrén M. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis 2007, 39(3):201-215. 10.1016/j.dld.2006.10.014, 17267314.
4. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006, 130(5):1377-1390. 10.1053/j.gastro.2006.03.008, 16678553.
5. Lyra A, Rinttilä T, Nikkilä J, Krogius-Kurikka L, Kajander K, Malinen E, Mättö J, Mäkelä L, Palva A. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol 15(47):5936-45. 20014457 , 2795180, 10.3748/wjg.15.5936.
6. Rajilić-Stojanović M. Diversity of the Human Gastrointestinal Microbiota - Novel Perspectives from High Troughput Analyses. 2007, University of Wageningen, Wageningen, The Netherlands.
7. Dupont AW. Post-infectious irritable bowel syndrome. Curr Gastroenterol Rep 2007, 9(5):378-384. 10.1007/s11894-007-0046-8, 17991338.
8. Lodes MJ, Cong Y, Elson CO, Mohamath R, Landers CJ, Targan SR, Fort M, Hershberg RM. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004, 113(9):1296-1306. 398429, 15124021.
9. Schoepfer AM, Schaffer T, Seibold-Schmid B, Muller S, Seibold F. Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterol Motil 2008, 20(10):1110-1118. 10.1111/j.1365-2982.2008.01166.x, 18694443.
10. Quigley EM. Changing face of irritable bowel syndrome. World J Gastroenterol 2006, 12(1):1-5.
11. Parkes GC, Brostoff J, Whelan K, Sanderson JD. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment. Am J Gastroenterol 2008, 103(6):1557-1567. 10.1111/j.1572-0241.2008.01869.x, 18513268.
12. Gecse K, Róka R, Ferrier L, Leveque M, Eutamene H, Cartier C, Ait-Belgnaoui A, Rosztóczy A, Izbéki F, Fioramonti J, Wittmann T, Bueno L. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut 2008, 57(5):591-599. 10.1136/gut.2007.140210, 18194983.
13. Róka R, Rosztóczy A, Leveque M, Izbéki F, Nagy F, Molnár T, Lonovics J, Garcia-Villar R, Fioramonti J, Wittmann T, Bueno L. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007, 5(5):550-555. 10.1016/j.cgh.2006.12.004, 17336590.
14. Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, Spiller RC. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol 2006, 101(6):1288-1294. 10.1111/j.1572-0241.2006.00672.x, 16771951.
15. Annaházi A, Gecse K, Dabek M, Ait-Belgnaoui A, Rosztóczy A, Róka R, Molnár T, Theodorou V, Wittmann T, Bueno L, Eutamene H. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice. Pain 2009, 144(1-2>):209-217. 1-, 19450926.
16. Krogius-Kurikka L, Kassinen A, Paulin L, Corander J, Mäkivuokko H, Tuimala J, Palva A. Sequence Analysis of Percent G+C Fraction Libraries of Human Faecal Bacterial DNA Reveals a High Number of Actinobacteria. BMC Microbiol 2009, (9):68. 10.1186/1471-2180-9-68, 2679024, 19351420.
17. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999, 45(Suppl 2):II43-7. 1766683, 10457044.
18. Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005, 100(2):373-382. 10.1111/j.1572-0241.2005.40312.x, 15667495.
19. Mättö J, Maunuksela L, Kajander K, Palva A, Korpela R, Kassinen A, Saarela M. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 2005, 43(2):213-222. 10.1016/j.femsim.2004.08.009, 15747442.
20. Maukonen J, Satokari R, Mättö J, Söderlund H, Mattila-Sandholm T, Saarela M. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med Microbiol 2006, 55(Pt 5):625-633. 10.1099/jmm.0.46134-0, 16585652.
21. Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007, 133(1):24-33. 10.1053/j.gastro.2007.04.005, 17631127.
22. Kajander K, Krogius-Kurikka L, Rinttilä T, Karjalainen H, Palva A, Korpela R. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome. Aliment Pharmacol Ther 2007, 26(3):463-473.
23. Apajalahti JH, Särkilahti LK, Mäki BR, Heikkinen JP, Nurminen PH, Holben WE. Effective recovery of bacterial DNA and percent-guanine-plus-cytosine-based analysis of community structure in the gastrointestinal tract of broiler chickens. Appl Environ Microbiol 1998, 64(10):4084-4088. 106608, 9758849.
24. Holben WE, Harris D. DNA-based monitoring of total bacterial community structure in environmental samples. Mol Ecol 1995, 4(5):627-631. 10.1111/j.1365-294X.1995.tb00263.x, 7582170.
25. Hicks RE, Amann RI, Stahl DA. Dual staining of natural bacterioplankton with 4',6-diamidino-2-phenylindole and fluorescent oligonucleotide probes targeting kingdom-level 16S rRNA sequences. Appl Environ Microbiol 1992, 58(7):2158-2163. 195749, 1379029.
26. Kane MD, Poulsen LK, Stahl DA. Monitoring the enrichment and isolation of sulfate-reducing bacteria by using oligonucleotide hybridization probes designed from environmentally derived 16S rRNA sequences. Appl Environ Microbiol 1993, 59(3):682-686. 202174, 7683181.
27. Edwards U, Rogall T, Blöcker H, Emde M, Böttger EC. Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S ribosomal RNA. Nucleic Acids Res 1989, 17(19):7843-7853. 10.1093/nar/17.19.7843, 334891, 2798131.
28. Staden R, Beal KF, Bonfield JK. The Staden package. Methods Mol Biol 2000, 132:115-130.
29. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22(22):4673-4680. 10.1093/nar/22.22.4673, 308517, 7984417.
30. Hall T. BioEdit. Biological sequence alignment editor for Windows. 1998, North Carolina State University, NC, USA., http://www.mbio.ncsu.edu/BioEdit/bioedit.html
31. Katoh K, Toh H. Recent developments in the MAFFT multiple sequence alignment program. Brief Bioinform 2008, 9(4):286-298. 10.1093/bib/bbn013, 18372315.
32. Felsenstein J. PHYLIP - Phylogeny Inference package (Version 3.2). Cladistics 1989, (17):164-166.
33. Schloss PD, Handelsman J. Introducing DOTUR, a computer program for defining operational taxonomic units and estimating species richness. Appl Environ Microbiol 2005, 71(3):1501-1506. 10.1128/AEM.71.3.1501-1506.2005, 1065144, 15746353.
34. Cole JR, Wang Q, Cardenas E, Fish J, Chai B, Farris RJ, Kulam-Syed-Mohideen AS, McGarrell DM, Marsh T, Garrity GM, Tiedje JM. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 2009, (37 Database):D141-5. 10.1093/nar/gkn879, 2686447, 19004872.
35. Lozupone C, Hamady M, Knight R. UniFrac--an online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics 2006, 7:371. 10.1186/1471-2105-7-371, 1564154, 16893466.
36. Schloss PD, Handelsman J. Introducing SONS, a tool for operational taxonomic unit-based comparisons of microbial community memberships and structures. Appl Environ Microbiol 2006, 72(10):6773-6779. 10.1128/AEM.00474-06, 1610290, 17021230.
37. Simpson EH. Measurement of diversity. Nature 1949, 163:688.
38. Shannon CE. A mathematical theory of communication. Bell Syst Tech J 1948, 27(379-423 and 623-656).
39. Chao A. Nonparametric estimation of the number of classes in a population. Scand J Statist 1984, (11):265-270.
40. Chao A, Lee S. Estimating the number of classes via sample coverage. J Amer Stat Assoc 1992, 87(417):210-217.
41. Good IJ. The population frequencies of species and the estimation of population parameters. Biometrika 1953, 40:237-264.
42. Pearson WR. Rapid and sensitive sequence comparison with FASTP and FASTA. Methods Enzymol 1990, 183:63-98. full_text, 2156132.
43. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 2007, 73(16):5261-5267. 10.1128/AEM.00062-07, 1950982, 17586664.
44. Wuyts J, Perriere G, Peer Y. The European ribosomal RNA database. Nucleic Acids Res 2004, (32 Database):D101-3. 10.1093/nar/gkh065, 308799, 14681368.
45. Collins MD, Lawson PA, Willems A, Cordoba JJ, Fernandez-Garayzabal J, Garcia P, Cai J, Hippe H, Farrow JA. The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int J Syst Bacteriol 1994, 44(4):812-826.
46. Kumar S, Tamura K, Nei M. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 2004, 5(2):150-163. 10.1093/bib/5.2.150, 15260895.
47. R Development Core Team R: A Language and Environment for Statistical Computing. Vienna, Austria 2007, R Development Core Team., http://www.r-project.org
48. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, Roca J, Doré J. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006, 55(2):205-211. 10.1136/gut.2005.073817, 1856500, 16188921.
49. Mai V, Braden CR, Heckendorf J, Pironis B, Hirshon JM. Monitoring of stool microbiota in subjects with diarrhea indicates distortions in composition. J Clin Microbiol 2006, 44(12):4550-4552. 10.1128/JCM.01542-06, 1698375, 17021054.
50. Quigley EM. Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases?. Chin J Dig Dis 2005, 6(3):122-132. 10.1111/j.1443-9573.2005.00202.x, 16045602.
51. Duck LW, Walter MR, Novak J, Kelly D, Tomasi M, Cong Y, Elson CO. Isolation of flagellated bacteria implicated in Crohn's disease. Inflamm Bowel Dis 2007, 13(10):1191-1201. 10.1002/ibd.20237, 17712838.
52. Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003, 98(7):1578-1583. 10.1111/j.1572-0241.2003.07542.x, 12873581.
53. Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, Jian R, Doré J. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003, 52(2):237-242. 10.1136/gut.52.2.237, 1774977, 12524406.
54. Si JM, Yu YC, Fan YJ, Chen SJ. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 2004, 10(12):1802-1805.
55. Young VB, Schmidt TM. Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol 2004, 42(3):1203-1206. 10.1128/JCM.42.3.1203-1206.2004, 356823, 15004076.
56. Barman M, Unold D, Shifley K, Amir E, Hung K, Bos N, Salzman N. Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect Immun 2008, 76(3):907-915. 10.1128/IAI.01432-07, 2258829, 18160481.